Metropolitan Life Insurance Company (MetLife)’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-235
| Closed | -$34K | – | 2815 |
|
|
2021
Q3 | $34K | Sell |
235
-259
| -52% | -$37.4K | ﹤0.01% | 2795 |
|
|
2021
Q2 | $91.1K | Hold |
494
| – | – | ﹤0.01% | 2615 |
|
|
2021
Q1 | $122K | Sell |
494
-16
| -3% | -$3.94K | ﹤0.01% | 2335 |
|
|
2020
Q4 | $144K | Hold |
510
| – | – | ﹤0.01% | 2158 |
|
|
2020
Q3 | $122K | Hold |
510
| – | – | ﹤0.01% | 2099 |
|
|
2020
Q2 | $169K | Buy |
+510
| New | +$169K | ﹤0.01% | 1916 |
|